We are monitoring the impact of COVID-19 on Thyroid Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 2167
Share on
Share on

Global Thyroid Cancer Market Analysis - By Treatment (Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs), By End User(Hospital, Oncology Centers, Hospital Pharmacies And Retail Pharmacies.) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast | 2019 - 2024

Pulished: August, 2019
ID: 2167
Pages: 180

Global Thyroid Cancer Market Size & Growth (2019 - 2024)

According to the Market Data Forecast, the size of the Global Thyroid cancer Market was valued at USD 275 million in 2019 and is expected to grow at a CAGR of 25.45% to reach USD 856.5 million by 2024.

Thyroid tumor is basically treated by surgery and radiotherapy. Chemotherapy has less part to play in the treatment. Essentially doxorubicin is utilized as an off-label drug for treating the patients with plastic thyroid cancer; likewise, some other off-name medications, for example, cisplatin and carboplatin are utilized, however, they have brought down response rates. The high development figure for the thyroid growth therapeutics market is essentially credited to a strong pipeline.

The thyroid cancer Market is strong, as there are 27 molecules that are in different stages of development. There are four molecules in Phase III (3) and Pre-registration (1). These drugs most probably get approved in the next 7 years. Zactima, XL184 and, Zybrestat have been granted orphan drug status by the FDA. Once the above molecules get approved, it will intensify the competition in Thyroid Cancer Market which results in substantial growth in the market. Current competition in the Thyroid cancer market is very less. Some effective treatments like Surgery exist and chemotherapy drugs are also used. Companies such as Doxorubicin which aims at managing conditions are prone to get larger success in the future.

Key Market Growth Drivers

  • The increasing number of thyroid cancer patients is major factor driving the demand of the market.
  • Rise in the awareness over the availability of different treatment procedures is lavishing the growth of the thyroid cancer market.
  • In addition, increasing investments in the healthcare centers by both private and public organizations are fueling the demand of the market.

Major Challenges

  • However, treatment for thyroid cancer involves high cost and this restraining the demand of the market slowly.
  • Also, cost for installation and maintenance of the equipment is a bit expensive which is a factor limiting the demand of the market.
  • The dearth of skilled persons in performing surgeries has remained a challenging factor for market developers.
  • Lack of standardization may also hinder the growth of the thyroid cancer market.

Potential Opportunities

  • Growing support from the government by changing schemes and the launch of reimbursement in favor of the common people is to set up growth opportunities for the market.
  • Increasing demand to improve the treatment procedures with quality is ascribed to bolster the demand of the market.
  • The rise in the expenditure on healthcare is likely to outshine the growth of the thyroid cancer market.
  • The growing geriatric population is also one of the factors fueling the growth of the market.

 

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Treatment, End-User, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc., Baxter International Inc., Abbott laboratories and App pharmaceuticals LLC.

 

This research report on Global Thyroid Cancer Market segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2024.

Thyroid Cancer Market Analysis – By Treatment:

  • Surgery
  • Iodine Therapy
  • External Therapy
  • Thyroxine treatment
  • Chemotherapy
  • Drugs

On the basis of treatment, the Surgery treatment procedure is witnessed in holding the highest shares of the market. Increasing demand for minimally invasive surgeries across the world which is more effective in curing the disease with less pain comparatively is boosting up the growth of the thyroid cancer market. The rise in the awareness over different techniques among physicians along with increasing training institutes is spurring the demand of this market.

Thyroid Cancer Market Analysis – By End User:

  • Hospitals
  • Oncology Centres
  • Hospital Pharmacies
  • Retail Pharmacies

On the basis of end-user, the hospital's segment is leading with the highest shares of the market. Increasing funds from non-government institutes to ensure quality therapeutic procedures is leveling up the growth of the market. Furthermore, increasing disposable income in urban areas is leveraging the growth rate of the market.

Regional Analysis:

North America is witnessed in the leading largest shares of the market. The adoption of advanced technologies and the launch of innovative techniques in healthcare centers is surging the growth of the market. Increasing capital income in both developed and developing countries is also a common factor gearing up the demand in this region. Europe is positioned second in leading the highest shares of the market. Stringent rules and regulations by the government in approving drugs to promote the wellbeing of patients after surgeries are magnifying the growth of the market. The Asia Pacific is accounted for in the fastest growth rate from recent years and is also expected to have significant growth opportunities in foreseen years. Increasing aging population and also rise in the scale of hospitals is broadening the demand of the market. The Middle East and Africa are deemed to have inclined growth rates in the coming years. 

Few of the notable companies operating in the Global Thyroid Cancer Market analyzed in this report are:

  1. Mylan Pharmaceuticals Inc.
  2. Alara Pharmaceutical Corporation
  3. Bristol Myers co.
  4. Teva parenteral medicines Inc.
  5. Jerome Stevens Pharmaceuticals Inc.
  6. Baxter International Inc.
  7. Abbott laboratories
  8. App pharmaceuticals LLC.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery     

                                5.1.3 Iodine Theraphy   

                                5.1.4 External radiotherapy        

                                5.1.5 Thyroxine treatment          

                                5.1.6  chemotherapy     

                                5.1.7 Drugs         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment         

                                5.1.9  Market Attractiveness Analysis, By Treatment       

                                5.1.10 Market Share Analysis, By Treatment       

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Oncology centers 

                                5.2.4 Hospital Pharmacies            

                                5.2.5 Retail Pharmacies 

                                5.2.6 Y-o-Y Growth Analysis, By End User             

                                5.2.7 Market Attractiveness Analysis, By End User           

                                5.2.8 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxter International Inc                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Mylan pharmaceuticals Inc                  

                8.3 Alara Pharmaceutical Corporation                    

                8.4  Bristol Myers co                       

                8.5  Abbott laboratories                               

                8.6 Teva parenteral medicines Inc                           

                8.7 App pharmaceuticals llc                         

                8.8  Jerome Stevens Pharmaceuticals Inc                             

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Thyroid Cancer Market By Region, From 2019-2024 ( USD Million )
  2. Global Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  3. Global Surgery Market By Region, From 2019-2024 ( USD Million )
  4. Global Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  5. Global External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  6. Global Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  7. Global chemotherapy Market By Region, From 2019-2024 ( USD Million )
  8. Global Drugs Market By Region, From 2019-2024 ( USD Million )
  9. Global Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  10. Global Hospitals Market By Region, From 2019-2024 ( USD Million )
  11. Global Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  12. Global Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  13. Global Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  14. North America Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  15. North America Surgery Market By Region, From 2019-2024 ( USD Million )
  16. North America Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  17. North America External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  18. North America Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  19. North America chemotherapy Market By Region, From 2019-2024 ( USD Million )
  20. North America Drugs Market By Region, From 2019-2024 ( USD Million )
  21. North America Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  22. North America Hospitals Market By Region, From 2019-2024 ( USD Million )
  23. North America Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  24. North America Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  25. North America Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  26. United States Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  27. United States Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  28. Canada Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  29. Canada Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  30. Europe Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  31. Europe Surgery Market By Region, From 2019-2024 ( USD Million )
  32. Europe Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  33. Europe External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  34. Europe Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  35. Europe chemotherapy Market By Region, From 2019-2024 ( USD Million )
  36. Europe Drugs Market By Region, From 2019-2024 ( USD Million )
  37. Europe Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  38. Europe Hospitals Market By Region, From 2019-2024 ( USD Million )
  39. Europe Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  40. Europe Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  41. Europe Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  42. U.K. Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  43. U.K. Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  44. Germany Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  45. Germany Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  46. France Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  47. France Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  48. Italy Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  49. Italy Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  50. Spain Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  51. Spain Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  52. Asia-Pacific Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  53. Asia-Pacific Surgery Market By Region, From 2019-2024 ( USD Million )
  54. Asia-Pacific Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  55. Asia-Pacific External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  56. Asia-Pacific Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  57. Asia-Pacific chemotherapy Market By Region, From 2019-2024 ( USD Million )
  58. Asia-Pacific Drugs Market By Region, From 2019-2024 ( USD Million )
  59. Asia-Pacific Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  60. Asia-Pacific Hospitals Market By Region, From 2019-2024 ( USD Million )
  61. Asia-Pacific Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  62. Asia-Pacific Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  63. Asia-Pacific Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  64. Japan Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  65. Japan Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  66. China Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  67. China Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  68. India Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  69. India Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  70. Australia Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  71. Australia Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  72. South Korea Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  73. South Korea Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  74. Latin America Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  75. Latin America Surgery Market By Region, From 2019-2024 ( USD Million )
  76. Latin America Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  77. Latin America External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  78. Latin America Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  79. Latin America chemotherapy Market By Region, From 2019-2024 ( USD Million )
  80. Latin America Drugs Market By Region, From 2019-2024 ( USD Million )
  81. Latin America Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  82. Latin America Hospitals Market By Region, From 2019-2024 ( USD Million )
  83. Latin America Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  84. Latin America Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  85. Latin America Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  86. Brazil Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  87. Brazil Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  88. Argentina Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  89. Argentina Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  90. Mexico Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  91. Mexico Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  92. Rest of Latin America Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  93. Rest of Latin America Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  94. Middle East & Africa Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  95. Middle East & Africa Surgery Market By Region, From 2019-2024 ( USD Million )
  96. Middle East & Africa Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  97. Middle East & Africa External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  98. Middle East & Africa Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  99. Middle East & Africa chemotherapy Market By Region, From 2019-2024 ( USD Million )
  100. Middle East & Africa Drugs Market By Region, From 2019-2024 ( USD Million )
  101. Middle East & Africa Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  102. Middle East & Africa Hospitals Market By Region, From 2019-2024 ( USD Million )
  103. Middle East & Africa Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  104. Middle East & Africa Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  105. Middle East & Africa Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  106. Middle East Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  107. Middle East Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  108. Africa Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  109. Africa Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample